Provided by Tiger Trade Technology Pte. Ltd.

OS Therapies

1.83
+0.08004.57%
Post-market: 1.830.00000.00%16:15 EDT
Volume:2.23M
Turnover:4.20M
Market Cap:85.04M
PE:-1.74
High:2.00
Open:1.80
Low:1.80
Close:1.75
52wk High:2.25
52wk Low:1.15
Shares:46.47M
Float Shares:33.71M
Volume Ratio:2.90
T/O Rate:6.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0524
EPS(LYR):-0.9829
ROE:-914.04%
ROA:-232.65%
PB:-7.14
PE(LYR):-1.86

Loading ...

Analysts Offer Insights on NA Companies: Waystar Holding Corp. (WAY) and OS Therapies Incorporated (OSTX)

TIPRANKS
·
Sep 15

OS Therapies announces full alignment on UK authorization application

TIPRANKS
·
Sep 15

OS Therapies Announces Prospectus for Secondary Share Resales

TIPRANKS
·
Sep 11

OS Therapies Files Prospectus for Resale of up to 5,874,094 Shares by Selling Stockholders

Reuters
·
Sep 11

OS Therapies Stockholders Approve Incentive Plan and Board

TIPRANKS
·
Sep 10

OS Therapies Shareholders Approve Amended 2023 Incentive Compensation Plan at Annual Meeting

Reuters
·
Sep 10

Analysts Offer Insights on NA Companies: OS Therapies Incorporated (OSTX) and SailPoint, Inc. (SAIL)

TIPRANKS
·
Sep 10

Analysts Offer Insights on NA Companies: OS Therapies Incorporated (OSTX) and Concentra Group Holdings Parent, Inc. (CON)

TIPRANKS
·
Sep 08

OS Therapies Reports 71.2% 3-Year Survival in Phase 2b OST-HER2 Metastatic Osteosarcoma Trial

Reuters
·
Sep 08

OS Therapies Management to Attend H.C. Wainwright Global Investment Conference

Reuters
·
Sep 02

OS Therapies Launches $75 Million At-The-Market Offering

TIPRANKS
·
Aug 22

OS Therapies Launches USD 75 Million At-the-Market Equity Offering Via Jefferies

Reuters
·
Aug 22

Os Therapies - Enters Open Market Sale Agreement with Jefferies - SEC Filing

THOMSON REUTERS
·
Aug 22

Analysts Offer Insights on NA Companies: OS Therapies Incorporated (OSTX) and Nicola Mining Inc. Unsponsored ADR (NICM)

TIPRANKS
·
Aug 18

OS Therapies Net Loss Widens to $19.03 Million in FY26 First Half; Revenue Remains no Revenue

Reuters
·
Aug 15

OS Therapies Wins FDA Type C Meeting to Review 2.5-Year Survival Data for OST-HER2 Phase 2b Osteosarcoma Trial

Reuters
·
Aug 13

OS Therapies Announces Convertible Note Financing and Warrants

TIPRANKS
·
Aug 13

Os Therapies - to Issue Senior Secured Convertible Notes up to $10 Mln in Private Placement - SEC Filing

THOMSON REUTERS
·
Aug 13

Os Therapies - Co & Its Wholly Owned Subsidiaries Entered Securities Purchase Agreement on August 10, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 13

OS Therapies Prices up to $10 Million Senior Secured Convertible Note Private Placement

Reuters
·
Aug 13